Big pharma racing to hedge patent expiry

Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of Concurrent explains. #News #Reuters #Newsfeed #PharmaIndustry #Biotech #Concurrent #PatentCliff #PharmaMergers #DrugPatents #BiopharmaDeals #BusinessNews #InvestingNews #HealthcareIndustry #MergersAndAcquisitions #2033PatentCliff #PharmaStocks #BiotechInvesting #DrugDevelopment #WallStreet #MarketNews #PharmaDeals #Reuters 👉 Subscribe: https://reut.rs/4b8fRGn Keep up with the latest ne…

Watch on source: https://www.youtube.com/watch?v=oYrBh71D-iM ↗